Cargando…
Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons
Proneural transcription factors (TFs) drive highly efficient differentiation of pluripotent stem cells to lineage‐specific neurons. However, current strategies mainly rely on genome‐integrating viruses. Here, we used synthetic mRNAs coding two proneural TFs (Atoh1 and Ngn2) to differentiate induced...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344911/ https://www.ncbi.nlm.nih.gov/pubmed/30387318 http://dx.doi.org/10.1002/sctm.18-0036 |
_version_ | 1783389496756142080 |
---|---|
author | Xue, Yingchao Zhan, Xiping Sun, Shisheng Karuppagounder, Senthilkumar S. Xia, Shuli Dawson, Valina L. Dawson, Ted M. Laterra, John Zhang, Jianmin Ying, Mingyao |
author_facet | Xue, Yingchao Zhan, Xiping Sun, Shisheng Karuppagounder, Senthilkumar S. Xia, Shuli Dawson, Valina L. Dawson, Ted M. Laterra, John Zhang, Jianmin Ying, Mingyao |
author_sort | Xue, Yingchao |
collection | PubMed |
description | Proneural transcription factors (TFs) drive highly efficient differentiation of pluripotent stem cells to lineage‐specific neurons. However, current strategies mainly rely on genome‐integrating viruses. Here, we used synthetic mRNAs coding two proneural TFs (Atoh1 and Ngn2) to differentiate induced pluripotent stem cells (iPSCs) into midbrain dopaminergic (mDA) neurons. mRNAs coding Atoh1 and Ngn2 with defined phosphosite modifications led to higher and more stable protein expression, and induced more efficient neuron conversion, as compared to mRNAs coding wild‐type proteins. Using these two modified mRNAs with morphogens, we established a 5‐day protocol that can rapidly generate mDA neurons with >90% purity from normal and Parkinson's disease iPSCs. After in vitro maturation, these mRNA‐induced mDA (miDA) neurons recapitulate key biochemical and electrophysiological features of primary mDA neurons and can provide high‐content neuron cultures for drug discovery. Proteomic analysis of Atoh1‐binding proteins identified the nonmuscle myosin II (NM‐II) complex as a new binding partner of nuclear Atoh1. The NM‐II complex, commonly known as an ATP‐dependent molecular motor, binds more strongly to phosphosite‐modified Atoh1 than the wild type. Blebbistatin, an NM‐II complex antagonist, and bradykinin, an NM‐II complex agonist, inhibited and promoted, respectively, the transcriptional activity of Atoh1 and the efficiency of miDA neuron generation. These findings established the first mRNA‐driven strategy for efficient iPSC differentiation to mDA neurons. We further identified the NM‐II complex as a positive modulator of Atoh1‐driven neuron differentiation. The methodology described here will facilitate the development of mRNA‐driven differentiation strategies for generating iPSC‐derived progenies widely applicable to disease modeling and cell replacement therapy. stem cells translational medicine 2019;8:112&12 |
format | Online Article Text |
id | pubmed-6344911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63449112019-01-28 Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons Xue, Yingchao Zhan, Xiping Sun, Shisheng Karuppagounder, Senthilkumar S. Xia, Shuli Dawson, Valina L. Dawson, Ted M. Laterra, John Zhang, Jianmin Ying, Mingyao Stem Cells Transl Med Pluripotent Stem Cells Proneural transcription factors (TFs) drive highly efficient differentiation of pluripotent stem cells to lineage‐specific neurons. However, current strategies mainly rely on genome‐integrating viruses. Here, we used synthetic mRNAs coding two proneural TFs (Atoh1 and Ngn2) to differentiate induced pluripotent stem cells (iPSCs) into midbrain dopaminergic (mDA) neurons. mRNAs coding Atoh1 and Ngn2 with defined phosphosite modifications led to higher and more stable protein expression, and induced more efficient neuron conversion, as compared to mRNAs coding wild‐type proteins. Using these two modified mRNAs with morphogens, we established a 5‐day protocol that can rapidly generate mDA neurons with >90% purity from normal and Parkinson's disease iPSCs. After in vitro maturation, these mRNA‐induced mDA (miDA) neurons recapitulate key biochemical and electrophysiological features of primary mDA neurons and can provide high‐content neuron cultures for drug discovery. Proteomic analysis of Atoh1‐binding proteins identified the nonmuscle myosin II (NM‐II) complex as a new binding partner of nuclear Atoh1. The NM‐II complex, commonly known as an ATP‐dependent molecular motor, binds more strongly to phosphosite‐modified Atoh1 than the wild type. Blebbistatin, an NM‐II complex antagonist, and bradykinin, an NM‐II complex agonist, inhibited and promoted, respectively, the transcriptional activity of Atoh1 and the efficiency of miDA neuron generation. These findings established the first mRNA‐driven strategy for efficient iPSC differentiation to mDA neurons. We further identified the NM‐II complex as a positive modulator of Atoh1‐driven neuron differentiation. The methodology described here will facilitate the development of mRNA‐driven differentiation strategies for generating iPSC‐derived progenies widely applicable to disease modeling and cell replacement therapy. stem cells translational medicine 2019;8:112&12 John Wiley & Sons, Inc. 2018-11-01 /pmc/articles/PMC6344911/ /pubmed/30387318 http://dx.doi.org/10.1002/sctm.18-0036 Text en © 2018 The Authors stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Pluripotent Stem Cells Xue, Yingchao Zhan, Xiping Sun, Shisheng Karuppagounder, Senthilkumar S. Xia, Shuli Dawson, Valina L. Dawson, Ted M. Laterra, John Zhang, Jianmin Ying, Mingyao Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons |
title | Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons |
title_full | Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons |
title_fullStr | Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons |
title_full_unstemmed | Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons |
title_short | Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons |
title_sort | synthetic mrnas drive highly efficient ips cell differentiation to dopaminergic neurons |
topic | Pluripotent Stem Cells |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344911/ https://www.ncbi.nlm.nih.gov/pubmed/30387318 http://dx.doi.org/10.1002/sctm.18-0036 |
work_keys_str_mv | AT xueyingchao syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT zhanxiping syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT sunshisheng syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT karuppagoundersenthilkumars syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT xiashuli syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT dawsonvalinal syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT dawsontedm syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT laterrajohn syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT zhangjianmin syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons AT yingmingyao syntheticmrnasdrivehighlyefficientipscelldifferentiationtodopaminergicneurons |